Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960

International Journal of Cancer

Volumn 110, Issue 2, 2004, Pages 155-169

  Levi, Fabio ^a,e   Lucchini, Franca ^a   Negri, Eva ^b   Boyle, Peter ^c   La Vecchia, Carlo ^a,b,d  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cancer; Europe; Mortality; Time trends

Indexed keywords

ADULT; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER REGISTRY; CZECH REPUBLIC; DATA BASE; EASTERN EUROPE; EUROPE; EUROPEAN UNION; FEMALE; HODGKIN DISEASE; HUMAN; HUNGARY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLAND; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; TOBACCO; UTERINE CERVIX CANCER; UTERUS CANCER; WORLD HEALTH ORGANIZATION;

EUROPE; FEMALE; HUMANS; MALE; NEOPLASMS; TIME FACTORS;

EID: 2342655033     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20097     Document Type: Review

References (133)

1. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Mortality from major cancer sites in the European Union, 1955-1998. Ann Oncol 2003;14:490-5.
2. Levi F, Lucchini F, Negri E, La Vecchia C. Cancer mortality in the European Union, 1988-1997: the fall may approach 80,000 deaths a year. Int J Cancer 2002;98:636-7.
3. Levi F, Lucchini F, Negri E, La Vecchia C. The end of the tobacco-related lung cancer epidemic in Europe. J Natl Cancer Inst 2003;95: 631-2.
4. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99-166.
5. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6.
6. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Cancer mortality in Europe, 1990-1994, and an overview of trends from 1955 to 1994. Eur J Cancer 1999;35:1477-516.
7. La Vecchia C, Lucchini F, Negri E, Boyle P, Maisonneuve P, Levi F. Trends of cancer mortality in Europe, 1955-1989: I, digestive sites; II, respiratory tract, bone, connective and soft tissue sarcomas, and skin; III, breast and genital sites; IV, urinary tract, eye, brain and nerves, and thyroid; V, lymphohaemopoietic and all cancers. Eur J Cancer 1992;28:132-235;514-99;927-98;1210-81;1509-81.
8. La Vecchia C, Negri E, Levi F, Decarli A, Boyle P. Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer 1998;34:118-41.
9. Quinn MJ, d'Onofrio A, Moller B, Black R, Martinez-Garcia C, Moller H, Rahu M, Robertson C, Schouten LI, La Vecchia C, Boyle P. Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol 2003;14:1148-52.
10. World Health Organization. Statistical information system: WHO mortality database. Geneva: World Health Organization, 2003.
11. World Health Organization. International classification of disease: 7th rev. Geneva: World Health Organization, 1957.
12. World Health Organization. International classification of disease: 8th rev. Geneva: World Health Organization, 1967.
13. World Health Organization. International classification of disease: 9th rev. Geneva: World Health Organization, 1977.
14. World Health Organization. International statistical classification of disease and related health problems: 10th rev. Geneva: World Health Organization, 1992.
15. Doll R, Smith PG. Comparison between registries: age-standardized rates. In: Waterhouse JAH, Muir CS, Shanmugaratnam K, Powell J, Peacham D, Whelan S, eds. Cancer incidence in five continents. vol. 4. Lyon: IARC, 1982. 671-5.
16. Percy C, Staneck E, Gloeckler L. Accuracy of cancer death certification and its effects on mortality statistics. Am J Publ Health 1981;71: 242-50.
17. Boyle P. Relative value of incidence and mortality data in cancer research. Recent Results Cancer Res 1989;114:41-63.
18. Shkolnikov V, McKee M, Vallin J, Aksel E, Leon D, Chenet L, Mesle F. Cancer mortality in Russia and Ukraine: validity, competing risks and cohort effects. Int J Epidemiol 1999;28:19-28.
19. Levi F, La Vecchia C, Lucchini F, Te VC, Franceschi S. Mortality from Hodgkin's disease and other lymphomas in Europe, 1960-1990. Oncology 1995;5:93-6.
20. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risk of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-308.
21. La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E. Epidemiology and prevention of oral cancer. Oral Oncol 1997;33: 302-12.
22. IARC. Monographs on the evaluation of carcinogenic risk to humans. Alcohol drinking. vol. 44. Lyon: IARC, 1988.
23. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 2001;85:1700-5.
24. Zatonski W. Alcohol and health: what is good for the French may not be for Russians. J Epidemiol Comm Health 1998;52:766-7.
25. Leon D, Chenet L, Shkolnikov VM, Zakharov S, Shapiro J, Rakhmanova G, Vassin S, McKee M. Huge variation in Russian mortality rates 1984-1994: artefact, alcohol, or what? Lancet 1997;350:383-8.
26. Barra S, Franceschi S, Negri E, Talamini R, La Vecchia C. Type of alcohol beverage and cancer of the oral cavity, pharynx and oesophagus in an Italian area with high wine consumption. Int J Cancer 1990;46:1017-20.
27. Day GL, Blot WJ, McLaughlin JK, Fraumeni JF Jr. Carcinogenic risk of dark vs. light liquor. Int J Cancer 1994;59:319-21.
28. La Vecchia C, Franceschi S, Favero A, Talamini R, Negri E. Alcohol intake and cancer of the upper digestive tract. Br Med J 1999;318: 1289-90.
29. Gronbaek M, Becker U, Johansen D, Tonnesen H, Jensen G, Sorensen TI. A population based cohort study of the association between alcohol intake and cancer of the upper digestive tract. Br Med J 1998;317:844-7.
30. La Vecchia C, Negri E, Lagiou P, Trichopoulos D. Oesophageal adenocarcinoma: a paradigm of mechanical carcinogenesis? Int J Cancer 2002;102:269-70.
31. Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995;4:85-92.
32. Levi F, Randimbison L, Lucchini F, Te VC, La Vecchia C. Epidemiology of adenocarcinoma and squamous cell carcinoma of the oesophagus. Eur J Cancer Prev 2001;10:91-6.
33. Levi F, Lucchini F, Gonzalez JR, Fernandez E, Negri E, La Vecchia C. Monitoring falls in gastric cancer mortality in Europe. Ann Oncol 2004;15:338-45.
34. World Cancer Research Fund. Food, nutrition, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 1997.
35. La Vecchia C, Negri E, D'Avanzo B, Franceschi S. Electric refrigeration use and gastric cancer risk. Br J Cancer 1990;62:136-7.
36. La Vecchia C, Munoz SE, Braga C, Fernandez E, Decarli A. Diet diversity and gastric cancer. Int J Cancer 1997;72:255-7.
37. Munoz N. Is Helicobacter pylori a cause of gastric cancer? an appraisal of the seroepidemiologic evidence. Cancer Epidemiol Biomarkers Prev 1994;3:445-51.
38. Trédaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer 1997;72:565-73.
39. Blot WJ. Preventing cancer by disrupting progression of precancerous lesions. J Natl Cancer Inst 2000;92:1860-70.
40. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, Mera D. Chemoprevention of gastric dysplasia: randomized trial of antioxydant supplements and anti-Helicobacter pylori treatment. J Natl Cancer Inst 2000;92: 1881-8.
41. Fernandez E, Bosetti C, La Vecchia C, Levi F, Fioretti F, Negri E. Sex differences in colorectal cancer mortality in Europe, 1955-1996. Eur J Cancer Prev 2000;9:99104.
42. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 2000;95: 868-77.
43. Walsh JME, Terdiman JP. Colorectal cancer screening: scientific review. JAMA 2003;289:1288-96.
44. Mandel JS. Sigmoidoscopy screening probably works, but how well is still unknown. J Natl Cancer Inst 2003;95:571-3.
45. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002;360: 942-4.
46. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanik ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene G, for the Writing Group of the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the Women's Health Initiative. JAMA 2002;288;321-33.
47. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998;75:347-54.
48. Colombo M. Hepatitis C virus and hepatocellular carcinoma. Semin Liver Dis 1999;19:263-9.
49. Kuper HE, Tzonou A, Kaklamani E, Hadziyannis S, Tasopoulos N, Lagiou P, Trichopoulos D, Stuver S. Hepatitis B and C in the etiology of hepatocellular carcinoma: a study in Greece using third-generation assays. Cancer Causes Control 2000;11:171-5.
50. La Vecchia C, Lucchini F, Franceschi S, Negri E, Levi F. Trends in mortality from primary liver cancer in Europe. Eur J Cancer 2000; 36:909-15.
51. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-85
52. Boyle P, Autier P, Bartelink H, Baselga J, Boffetta P, Burn J, Burns HJ, Christensen L, Denis L, Dicato M, Diehl V, Doll R, et al. European code against cancer and scientific justification: third version (2003). Ann Oncol 2003;14:973-1005.
53. Chen ZM, Lin BQ, Boreham J, Wu YP, Chen JS, Peto R. Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths. Int J Cancer 2003;107:106-12.
54. Kuper H, Tzonou A, Kaklamani E, Hsieh CC, Lagiou P, Adami HO, Trichopoulos D, Stuver SO. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000;85:498-502.
55. Fraumeni JF Jr, Devesa SS, McLaughlin JK, Stanford JL. Biliary tract cancer. In: Schottenfeld D, Fraumeni J Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996. 794-812.
56. McMahon AJ, Fiscbacher CM, Frame SH, MacLeod MCM. Impact of laparoscopic cholecystectomy: a population-based study. Lancet 2000;356:1632-7.
57. Levi F, Lucchini F, Negri E, La Vecchia C. The recent decline in gallbladder cancer mortality in Europe. Eur J Cancer Prev 2003;12: 265-7.
58. Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson GM, Schwartz AG, Brown LM, Greenberg RS, Schoenberg JB, Pottern LM, Hoover RN, Fraumeni JF Jr. Diabetes mellitus, other medical conditions and familial history as risk factors for pancreatic cancer. Br J Cancer 1999;60:1830-7.
59. World Health Organization. Tobacco or health: a global status report. Geneva: World Health Organization, 1997.
60. Anderson KE, Potter JD, Mack TM. Pancreatic cancer. In: Schottenfeld D, Fraumeni J Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996. 725-71.
61. Levi F, Lucchini F, Negri E, La Vecchia C. Pancreatic cancer mortality in Europe: the levelling of an epidemic. Pancreas 2003;27:139-42.
62. Ghadirian P, Simard A, Baillargeaon J, Maisonneuve P, Boyle P. Nutritional factors and pancreatic cancer in the Francophone community in Montreal, Canada. Int J Cancer 1991;47:1-6.
63. Zatonski W, Przewozniak K, Howe GR, Maisonneuve P, Walker AM, Boyle P. Nutritional factors and pancreatic cancer: a case-control study from south-west Poland. Int J Cancer 1991;48:390-4.
64. Howe GR, Ghadirian P, Bueno de Mesquita HB, Zatonski WA, Baghurst PA, Miller AB, Simard A, Baillargeon J, de Waard F, Przewozniak K. A collaborative case-control study of nutrient intake and pancreatic cancer within the SEARCH programme. Int J Cancer 1992;51:365-72.
65. Soler M, Chatenoud L, La Vecchia C, Franceschi S, Negri E. Diet, alcohol, coffee and pancreatic cancer: final results from an Italian study. Eur J Cancer Prev 1998;7:455-60.
66. Talamini R, Bosetti C, La Vecchia C, Dal Maso L, Levi F, Bidoli E, Negri E, Pasche C, Vaccarella S, Barzan L, Franceschi S. Combined effect of tobacco and alcohol consumption on laryngeal cancer risk: a case-control study. Cancer Causes Control 2002;13:957-64.
67. Shkolnikov V, McKee M, Leon D, Chenet L. Why is the death rate from lung cancer falling in the Russian Federation? Eur J Epidemiol 1999;15:203-6.
68. Jemal A, Chu KC, Tarone RE. Recent trends in lung cancer mortality in the United States. J Natl Cancer Inst 2001;93:277-83.
69. Brennan P, Bray I. Recent trends and future directions for lung cancer mortality in Europe. Br J Cancer 2002;87:43-8.
70. Borras JM, Fernandez E, Gonzalez JR, Negri E, Lucchini F, La Vecchia C, Levi F. Lung cancer mortality in European regions (1995-97). Ann Oncol 2003;14:159-61.
71. La Vecchia C, Levi F. Lung cancer in Europe: the levelling of an epidemic. Eur J Publ Health 2003;13:1-2.
72. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666-72.
73. Price B. Analyses of current trends in US mesothelioma incidence. Am J Epidemiol 1997;145:211-8.
74. Peto J. The hygiene standard for crysotile asbestos. Lancet 1978;1: 484-9.
75. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000; 44:565-601.
76. Hemminki K, Li X. Mesothelioma incidence seems to have levelled off in Sweden. Int J Cancer 2003;103:145-6.
77. Ulvestad B, Kjaerheim K, Moller B, Andersen A. Incidence trends of mesothelioma in Norway, 1965-1999. Int J Cancer 2003;107:94-8.
78. Zahm SH, Fraumeni J Jr. The epidemiology of soft tissue sarcomas. Semin Oncol 1997;24:504-14.
79. La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in young and middle age. Int J Cancer 1999;81:62-6.
80. Naldi L, Imberti LG, Parazzini F, Gallus S, La Vecchia C. Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer 2000; 88:2703-10.
81. Bulliard JL, Raymond L, Levi F, Schueler G, Enderlin F, Pellaux S, Torhorst J. Prevention of cutaneous melanoma: an epidemiological evaluation of the Swiss campaign. Rev Epidemiol Santé Publ 1992; 40:431-8.
82. Thörn M, Pontèn P, Bergström R, Sparèn P, Adami HO. Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden. Br J Cancer 1994;70:743-8.
83. Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000;82:1887-91.
84. Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 2000;355:1822.
85. Office for National Statistics. Mortality statistics: review of the registrar general of deaths by cause, sex and age in England and Wales, 1993 (revised) and 1994. London: HMSO, 1996.
86. Jatoi I, Miller AB. Why is breast cancer mortality declining? Lancet Oncol 2003;4:251-4.
87. Levi F, Lucchini F, Negri E, La Vecchia C. The fall in breast cancer mortality in Europe. Eur J Cancer 2001;37:1409-12.
88. Levi F, Lucchini F, Negri E, Franceschi S, La Veccchia C. Cervical cancer mortality in young women in Europe: patterns and trends. Eur J Cancer 2000;36:2266-71.
89. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
90. Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 2003;361:1159-67.
91. De Villiers EM. Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer 2003;103:705-8.
92. La Vecchia C, Franceschi S, Decarli A, Fasoli M, Gentile A, Tognoni G. Cigarette smoking and the risk of cervical neoplasia. Am J Epidemiol 1986;123:22-9.
93. Bosetti C, Negri E, Trichopoulos D, Franceschi S, Beral V, Tzonou A, Parazzini F, Greggi S, La Vecchia C. Long-term effects of oral contraceptives on ovarian cancer risk. Int J Cancer 2002;102:262-65.
94. Franceschi S, Levi F, La Vecchia C. Survival after ovarian cancer treatment. JAMA 1993;270:1196-7.
95. Tarone RE, Chu KC, Brawley OW. Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates. Epidemiology 2000;11:167-70.
96. Hsing AW, Tsao L, Devesa S. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000;85:60-7.
97. Boyle P. Prostate cancer: creation and control of an epidemic. J Epidemiol Biostat 1996;1:65-7.
98. Levi F, La Vecchia C, Boyle P. The rise and fall of prostate cancer. Eur J Cancer Prev 2000;9:381-5.
99. Hsing AW, Devesa SS. Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev 2001;23:3-13.
100. Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Gil T, Collette L, Pierart M. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997;337:295-300.
101. Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadebectomy in men with node-positive prostate cancer. N Engl J Med 1999;341:1781-8.
102. Chu KC, Tarone RE, Freeman HP. Trends in prostate cancer mortality among black men and white men in the United States. Cancer 2003; 97:1507-16.
103. Levi F, Lucchini F, Boyle P, Negri E, La Vecchia C. Testicular cancer mortality in Eastern Europe. Int J Cancer 2003;103:574.
104. Negri E, La Vecchia C. Epidemiology and prevention of bladder cancer. Eur J Cancer Prev 2001;10:714.
105. McLaughlin JK, Blot WJ, Devesa SS, Fraumeni JF Jr. Renal cancer. In: Schottenfeld D, Fraumeni J Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996. 1142-55.
106. Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000; 343:1305-11.
107. Inskip PD, Devesa S, Fraumeni JF Jr. Trends in incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control 2003;14:251-7.
108. Franceschi S, Preston-Martin S, Dal Maso L, Negri E, La Vecchia C, Mack WJ, McTiernan A, Kolonel L, Mark SD, Mabuchi K, Wingren G, Galanti R, Hallquist A, Glattre E, Lund E, Levi F, Linos D, Ron E. A pooled analysis of case-control studies of thyroid cancer: IV, benign thyroid diseases. Cancer Causes Control 1999;10:583-95.
109. Ron E. Thyroid cancer. In: Schottenfeld D, Fraumeni J Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996. 1000-21.
110. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Trends in mortality from Hodgkin's disease in Western and Eastern Europe. Br J Cancer 2002;87:291-3.
111. Bray I, Brennan P, Boffetta P. Recent trends and future projections of lymphoid neoplasms-Bayesian age-period-cohort analysis. Cancer Causes Control 2001;12:813-20.
112. Howe HL, Wingo PA, Thun MJ, Ries LAG, Rosenberg HM, Feigal EG, Edwards BK. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001;93:824-42.
113. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from non-Hodgkin's lymphomas. Leukemia Research 2002;26:903-8.
114. Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S. B-cell non-Hodgkin lymphoma and hepatitis C virus infection: a systematic review of 66 studies. Int J Cancer, in press.
115. Turesson I, Zettervall O, Cuzick J, Waldenström JG, Velez R. Comparison of trends in the incidence of multiple myeloma in Malmö, Sweden, and other countries, 1950-1979. N Engl J Med 1984;310: 421-4.
116. Levi F, Lucchini F, Negri E, Barbui T, La Vecchia C. Trends in mortality from leukaemia in subsequent age groups. Leukemia 2000; 14:1980-5.
117. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998;338:605-15.
118. Edwards BK, Howe HL, Ries LAG, Thun MJ, Rosenberg HM, Yancik R, Wingo PA, Jemal A, Feigal EG. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002;94:2766-92.
119. Wingo PA, Cardinez CJ, Landis SH, Greenlee RT, Ries LAG, Anderson RN, Thun MJ. Long-term trends in cancer mortality in the United States, 1930-1998. Cancer 2003;97(Suppl 11):3133-275.
120. Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D. Cancer and Mediterranenan dietary traditions. Cancer Epidemiol Biomarkers Prev 2000;9:869-73.
121. Bosetti C, Gallus S, Trichopoulou A, Talamini R, Franceschi S, Negri E, La Vecchia C. Influence of the Mediterranean diet on the risk of cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 2003;12:1091-4.
122. Gallus S, Bosetti C, Negri E, Talamini R, Montella M, Conti E, Franceschi S, La Vecchia C. Does pizza protect against cancer? Int J Cancer 2003;107:283-4.
123. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
124. Adami HO, Trichopoulos D. Obesity and mortality from cancer. N Engl J Med 2003;348:1623-4.
125. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 1999;341:427-34.
126. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001;91:421-30.
127. IARC. Handbook of cancer prevention. Weight control and physical activity. vol. 6. Lyon: IARC, 2002.
128. La Vecchia C, Chatenoud L, Franceschi S, Soler M, Parazzini F, Negri E. Vegetables and fruit and human cancer: update of an Italian study. Int J Cancer 1999;82:151-2.
129. IARC. Handbook of cancer prevention. Fruit and vegetables. vol. 8. Lyon: IARC, 2003.
130. Garattini S, La Vecchia C. Perspectives in cancer chemotherapy. Eur J Cancer 2001;37:S128-47.
131. Garattini S, Bertele V. Efficacy, safety, and cost of new anticancer drugs. Br Med J 2002;325:269-71.
132. Garattini S. New approaches to cancer therapy. Ann Oncol 2003;14: 815-6.
133. La Vecchia C, Franceschi S, Levi F. Epidemiological research on cancer with a focus on Europe. Eur J Cancer Prev 2003;12:5-14.